MedicinesFAQ

Amediplase Uses, Dosage, Side Effects and more

Amediplase is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain from the A-chain of tissue plasminogen activator (t-PA) and the carboxy terminal region of pro-urokinase. [MeSH]

Attribute Details
Trade Name Amediplase
Generic Amediplase
Amediplase Other Names Amediplase
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

Uses

Investigated for use/treatment in myocardial infarction and thrombosis.

Food Interaction

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.